$TirzepatidePriceGuide
Policy

Corrections policy and log

How we fix errors, and a dated record of what we changed.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.

How corrections work

If a price, date or statement is wrong, we check it against the primary source, fix the page and log the change here with its date. Send corrections to tirzepatidepriceguide@gmail.com or use the correction form.

Corrections log

  1. November 10, 2026: Removed statements that this site is independent, is not affiliated with or paid by the providers it compares, and accepts no affiliate commissions. They appeared in the site header bar, page notes, the footer and the About, Advertising disclosure, How we make money, Editorial team and Medical review pages. Every page now carries the standard affiliate disclosure in the footer.
  2. November 10, 2026: Removed claims about NexLife that its own pages do not support: 503B partner facilities and six partner pharmacies, MD/DO-supervised care, LegitScript certification, labs included, "Care360" coaching, certificates of analysis on request and a Trustpilot rating. Pages now cite the three 503A pharmacies named on NexLife's plan pages.
  3. November 10, 2026: Updated NexLife's prices to those effective November 6, 2026: tirzepatide $129 month to month and $125, $119 and $115 a month on 3-, 6- and 12-month plans (earlier $169, $159, $149 and $139); semaglutide $109, $105, $99 and $95 (earlier $139, $132, $125 and $119).
  4. November 10, 2026: Removed wording that called NexLife the "lowest predictable all-in cost". In our index, Collective, WellMedr and Mondae show lower all-in figures under membership, sale or prepaid terms, and Eden matches NexLife's month-to-month price.
  5. November 10, 2026: Corrected the Zepbound 5 mg self-pay price on our dose pages: Lilly lists $399 at 5 mg, not $499. The higher late-refill prices apply at 7.5 mg ($499) and 10–15 mg ($699).
  6. November 10, 2026: Replaced "same molecule" wording: compounded tirzepatide is made with the drug in Zepbound and Mounjaro but is not the same product.
  7. November 10, 2026: Removed the pages and table rows for one provider we no longer cover; its old URLs redirect to related pages.
  8. November 10, 2026: Updated bylines: pages are now researched by Dr. Parmis and medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).
  9. November 10, 2026: Replaced the July 2026 price table, which used a third-party index, with first-party reads dated October 15, 2026 (NexLife November 6, 2026). The July snapshot remains online as a dated page.